Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model
- Autori: Petta, S.; Di Marco, V.; Bruno, S.; Enea, M.; Calvaruso, V.; Boccaccio, V.; Rossi, S.; Craxì, A.; Cammà , C.
- Anno di pubblicazione: 2016
- Tipologia: Articolo in rivista (Abstract in rivista)
- OA Link: http://hdl.handle.net/10447/191006
Abstract
No published study to date has provided a careful analysis of the effects of a sustained viral response(SVR) on the outcomes of patients with compensated hepatitis C virus(HCV)-related cirrhosis in relation to the degree of portal hypertension. Therefore, we estimated the impact of achieving SVR on disease progression, hepatocellular carcinoma(HCC) development and mortality in a large cohort of HCV patients with cirrhosis with or without oesophageal varices(OVs) at the start of antiviral therapy.